Living Cell Technologies Ltd. (AU:1AI) has released an update.
Algorae Pharmaceuticals Limited reported a 198% increase in total revenue and other income, rising to $125,200 for the full year ended June 30, 2024, though the company’s net loss marginally improved by 1% to $(2,095,562). The company has not declared any dividends, maintaining a consistent policy from the previous year, and attributes the detailed explanations of the results to the ASX release.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
